ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,337Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 29

$555K Total Retail Price of All Prescriptions

Rank: 12 out of 29

441 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 441 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 441 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 9,114 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 462 461 1 4
LISINOPRIL 397 389 2 2
AMLODIPINE BESYLATE 305 298 3 5
LEVOTHYROXINE SODIUM 286 284 4 1
DONEPEZIL HCL 239 239 5 9
TRAZODONE HCL 234 229 6 22
GALANTAMINE HBR 233 223 7 81
NAMENDA 231 231 8 12
FUROSEMIDE 207 205 9 3
MIRTAZAPINE 206 206 10 13
POTASSIUM CHLORIDE 196 176 11 6
OMEPRAZOLE 192 187 12 8
GABAPENTIN 191 180 13 10
METOPROLOL TARTRATE 186 183 14 15
SERTRALINE HCL 174 161 15 17
HYDROCHLOROTHIAZIDE 172 154 16 20
HYDROCODONE-ACETAMINOPHEN 168 151 S3 17 7
LOSARTAN POTASSIUM 134 132 18 28
ALENDRONATE SODIUM 133 133 19 26
METOPROLOL SUCCINATE 128 128 20 16
CITALOPRAM HBR 126 123 21 11
METFORMIN HCL 123 119 22 19
CYMBALTA 114 114 23 29
ATENOLOL 107 107 24 23
TRIAMTERENE-HCTZ 101 101 25 48
ATORVASTATIN CALCIUM 99 97 26 25
TAMSULOSIN HCL 87 87 27 31
CARBIDOPA-LEVODOPA 77 77 28 42
FLUTICASONE PROPIONATE 76 76 29 43
DIOVAN 75 75 30 35
NEXIUM 74 74 31 47
PRAVASTATIN SODIUM 73 72 32 18
ISOSORBIDE MONONITRATE ER 69 68 33 44
KLOR-CON M10 66 65 34 142
TRAMADOL HCL 65 55 35 24
CRESTOR 62 62 36 62
EXELON 61 61 37 38
ZOLPIDEM TARTRATE 56 54 38 30
SPIRIVA 54 54 39 96
WARFARIN SODIUM 54 54 39 14
ROPINIROLE HCL 52 40 41 94
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 50 42 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.